| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.23 | 5e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.003 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.14 | 0.004 |